Guidance for market authorization requirements for COVID-19 drugs: Overview (English, HTML)
View metadata and access the original English HTML file: Guidance for market authorization requirements for COVID-19 drugs: Overview.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2022-07-28
This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file